Symbiox Investment & Trading Co Ltd

Symbiox Investment & Trading Co Ltd, a Non Banking Financial Company (NBFC), recorded a fresh 52-week low of Rs.1.72 today, marking a significant decline amid broader market gains. The stock has underperformed its sector and key indices, reflecting ongoing concerns about its financial health and market positioning.

Symbiox Investment & Trading Co Ltd, a Non Banking Financial Company (NBFC), has touched a new 52-week low of Rs.1.84 today, marking a significant decline in its stock price amid broader market gains.

Symbiox Investment & Trading Co Ltd, a Non Banking Financial Company (NBFC), has touched a new 52-week low of Rs.1.84 today, marking a significant decline in its stock price amid broader market gains. This latest low reflects ongoing pressures on the stock, which has underperformed its sector and the broader market over the past year.

Symbiox Investment & Trading Co Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has declined to a fresh 52-week low of Rs.1.9 today, marking a significant downturn amid a broader market environment where the Sensex remains near its yearly highs.

Symbiox Investment & Trading Co Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 October 2025. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with the most up-to-date analysis.

Symbiox Investment & Trading Co, a Non Banking Financial Company (NBFC), has reached a new 52-week low of Rs.2, marking a significant decline amid a challenging market environment. The stock has experienced a sustained downward trend, reflecting a series of financial and market factors impacting its performance.

Symbiox Investment & Trading Co, a Non Banking Financial Company (NBFC), has reached a new 52-week low of Rs.2.1 today, marking a significant decline amid a broader market environment where the Sensex trades near its 52-week high. The stock has been under pressure for several sessions, reflecting ongoing concerns about its financial performance and valuation metrics.

Symbiox Investme, a microcap player in the Non Banking Financial Company (NBFC) sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. This adjustment highlights shifts in key analytical parameters that investors should consider carefully.

Symbiox Investment & Trading Co has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and a lack of sellers, suggesting the possibility of a multi-day circuit scenario for this Non Banking Financial Company (NBFC) stock.

Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers in the market. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market indices.

Symbiox Investment & Trading Co Ltd has attracted extraordinary buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights a strong demand for the stock despite recent underperformance relative to broader indices and its sector peers.

Symbiox Investment & Trading Co Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention in the Non Banking Financial Company (NBFC) sector.

Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock registering consecutive declines and no visible buying interest. The Non Banking Financial Company (NBFC) has seen its shares fall sharply over multiple time frames, signalling distress selling and a challenging market environment for investors.

Symbiox Investment & Trading Co Ltd, a player in the Non Banking Financial Company (NBFC) sector, is currently experiencing severe selling pressure, with only sell orders present in the market queue. This unusual trading pattern signals distress selling and highlights the challenges the stock faces amid broader market fluctuations.

Symbiox Investment & Trading Co Ltd is experiencing notable selling pressure, continuing a trend of losses. The stock has declined significantly over various time frames, contrasting with the performance of the Sensex. Factors such as market sentiment and operational challenges in the NBFC sector may be influencing this downturn.

Symbiox Investment & Trading Co Ltd is experiencing significant selling pressure, with a notable decline today amid a contrasting performance from the Sensex. The stock has faced consecutive losses, underperforming both weekly and yearly benchmarks, reflecting broader market trends and sector-specific concerns.